Jazz Pharmaceuticals 483, May 2012

Jazz Pharmaceuticals 483, May 2012

Peter Baker FDA, Jennifer Johnson FDA$119.00

FDA investigators audited the Jazz Pharmaceuticals - Palo Alto, CA, United States facility and issued inspectional observations (via FDA 483) on 30 May 2012.

Add To Cart

Product details

  • Category: Human Drugs
  • Inspection end: 30 May 2012
  • Location: Palo Alto, United States